SuperSmart← Back to DiscoverDiscover
RESEARCH DRAFT

Research draft. Conclusions may change; review the sources and limitations before relying on them.

RESEARCH DRAFT · NOT A VERIFIED CONCLUSION

A device correction began 30 days before its FDA database posting.

Eighteen FDA product records share one recall event and a 30-day initiation-to-posting interval—not 18 independent incidents.

research_draftUpdated 2026-09-080 recorded actions
Conceptual generated illustration of documents and civic architectureCONCEPTUAL ILLUSTRATION

Monitor this connection

Sign in to your account to monitor updates
2Recorded evidence rows
0Investigation actions
6Review limitations
0Recorded answers

What this page shows

FDA event 95129 describes a potential interaction between Shockwave Coronary IVL catheters and left-sided Impella pumps. All 18 product records share August 5, 2024 as the initiation date and September 4, 2024 as the posting date—a 30-day interval. The source also describes correction letters sent on August 5. Could a monitoring feed based only on database postings miss earlier manufacturer communications? This example establishes a date difference, not what any specific hospital knew or when.

Recorded evidence

FDA openFDA · original records
All 18 product records for recall event 951292024-08-05 initiation; 2024-09-04 posting
↗
FDA recall database
Recall Z-2968-2024 — event 95129 and correction-letter date2024-09-04 posting
↗

Limitations & review notes

  • Research draft. Conclusions may change; review the sources and limitations before relying on them.
  • Restored archival research draft: not independently reverified for this republication and not actively monitored. Check the linked originals and dated scope before relying on it.
  • Posting date is not customer-notification date. The records describe letters sent on August 5; this is not evidence that customers waited 30 days for a warning.
  • Eighteen recall numbers share event 95129. They must not be described as 18 independent failures, injuries or safety events.
  • The finding is a reproducible computation over this retrieved source set, not proof of a general FDA posting delay or first-ever discovery. A broader cohort is needed to establish how common this interval is.
  • No corporate-ownership connection is established by this finding.

Questions this connection opens

  1. Across FDA device corrections, what is the distribution of days between event initiation, documented manufacturer notification and FDA database posting? Group product records by event before counting; preserve the three dates separately, report missing notification dates and identify which earlier public sources a monitoring system could actually have accessed.
  2. For FDA event 95129, which product and serial-number ranges overlap an authorized hospital inventory, and when did that hospital receive the manufacturer notice? Separate product eligibility, documented receipt and completed corrective action; do not infer awareness from a database date.
Go deeper

Ask a follow-up question, compare another company, or review the supporting evidence.

Ask a follow-up